• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Schrodinger Inc (NQ: SDGR )

    19.04 -0.30 (-1.55%)
    Streaming Delayed Price Updated: 1:06 PM EDT, Jul 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 236,355
    Open 19.29
    Bid (Size) 19.01 (4)
    Ask (Size) 19.04 (1)
    Prev. Close 19.34
    Today's Range 19.01 - 19.47
    52wk Range 18.21 - 59.24
    Shares Outstanding 62,027,061
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Largest Clinical-Stage BioTech Drug Stocks Declined 6%
    Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... 
    Via Talk Markets
    AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
    The global 
    Via Talk Markets

    Performance

    YTD
    -45.80%
    -45.80%
    1 Month
    -11.52%
    -11.52%
    3 Month
    -27.69%
    -27.69%
    6 Month
    -45.80%
    -45.80%
    1 Year
    -60.86%
    -60.86%

    More News

    Read More
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
    Via Talk Markets
    The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Schrödinger to Present at Jefferies Global Healthcare Conference
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    What's the Difference Between Biotech Stocks and TechBio Stocks?
    Via The Motley Fool
    Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
    Via Talk Markets
    The 7 AI Categories Declined, On Average, The First Week Of May
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
    Via Talk Markets
    Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    SDGR Stock Earnings: Schrodinger Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Schrödinger Reports First Quarter 2024 Financial Results
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Schrödinger to Announce First Quarter 2024 Financial Results on May 1
    From Schrödinger
    Via Business Wire
    5 Healthcare Stocks to Buy for 2024
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Invest Like Bill Gates With These 3 AI Stocks to Buy
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Shhh! 7 Small-Cap Stocks That Can Double by 2025
    Via InvestorPlace
    Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.